Wikipedia -WSS

Wikipedia

author：leisure time 2025-10-01 10:38:10 - browse：9534

Adam's take main illustration — Molly Ferguson/STAT

Annovis Bio had my biotech bull%^&! meter running red after it made a late change to the design of a Phase 3 study in Parkinson’s disease. But then I got an extraordinary explanation from CEO Maria Maccecchini. Now, I’m less worried about data spin because, by her own admission, the odds that the study succeeds, post endpoint change, are a lot lower.

Results from the completed Parkinson’s study, which is investigating Annovis’ drug called buntanetap, are well past due because of what the company has described as ongoing “data cleaning efforts.” The delay was announced on Jan. 24. Two weeks later, on Feb. 6, the primary efficacy endpoint of the study was changed, according to an update posted to the U.S. government’s clinical trials database.

Red flag, I thought, until I emailed Maccecchini, asking for an explanation. In response, she told me Annovis made the key endpoint change in August, based on a recommendation from officials at the Food and Drug Administration after the agency had reviewed data from an interim analysis of the study. It took the company another six months to update the study design in the ClinicalTrials.gov database, for reasons she did not explain.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： BioMarin wins approval for gene therapy to treat hemophilia A
Next article： Woodcock on FDA’s accelerated approval and her next chapter

focus

WSS

Inflation cooled significantly in June, bringing price hikes close to normal levels

Blinken talks high

Readout LOUD podcast: Vertex data, Aduhelm, & Woodcock retires

New Ultima Genomics DNA sequencer can read genome for $100

China sends large group of warplanes, navy ships towards Taiwan in forceful display

Novo Nordisk to expand supply of Wegovy for U.S. patients

explore

Wikipedia

focus

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

A $475,000 price tag for a new cancer drug: crazy or meh?

At least 13 dead in Texas as scorching temps continue

France's anti

Anesthesiologist group: stop taking Ozempic before surgery

SAMSHA loosens regulations on methadone treatment centers

Heart attack and stroke risk calculators need revising

Some dementia cases could be undiagnosed liver disease

How to save PrEP access — and even expand it

Inflation cooled significantly in June, bringing price hikes close to normal levels

hotspot

Va. Republicans encourage early voting, a target of Trump's, ahead of fall elections

Vermont grapples with historic flooding as more rainstorms head for Northeast

Commercial surrogacy can be ethical, despite pope’s claims

Tommy Tuberville reverses his claim that white nationalists are unfairly labeled racist

The lessons of Aduhelm, an Alzheimer's drug that was not to be

Biden administration opens offers in Medicare drug price negotiations

entertainment

focus

focus

Wikipedia